drugset / Trial / NCT00938639
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of the study is to determine whether CSL425 is a safe and effective vaccine for eliciting an immune response to H1N1 influenza in healthy adults.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-09
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CSL425 | Vaccine | 15 ug | Intramuscular |
| Subject | CSL425 | Vaccine | 30 ug | Intramuscular |